Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04926597

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

This study is to compare the sustained post-discharge nutritional support to reach individual energy and protein goals to usual care home nutrition in medical patients at nutritional risk.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitari Vall Hebron de Barcelona, Barcelona, Spain

Loading trial locations.

About this study

Malnutrition is a strong and independent long-term risk factor for mortality, rehospitalisation and functional decline, particularly in the elderly, polymorbid medical patient population. The randomized-controlled Effect of early nutritional support on Frailty, Functional Outcomes and Recovery of malnourished medical inpatients Trial (EFFORT, Lancet 2019) included 2028 patients in eight Swiss hospitals and found that nutritional support during the inhospital stay reduces very efficiently the risk for complications and mortality with numbers needed to treat (NNT) of 23 and 37, respectively.

Yet, the nutritional intervention was not continued after hospital discharge of patients and long-term follow-up data of patients showed a lack of sustained effect of the initial nutritional support strategy. There is a current lack of trial data investigating whether long-term use of nutritional support has a sustained effect on clinical outcomes in this patient population. This study is to compare the continuous use of nutritional support with the use of approved oral nutritional supplements to reach protein and energy goals and to analyze whether medical patients at nutritional risk show a sustained benefit from long-term nutritional support after hospital discharge, and why and how nutritional support affects the course of disease from a mechanistic physio-pathological standpoint.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Informed Consent as documented by signature
  • Adult (age ≥18 years), medical patients
  • Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status [weight loss >5% in 3 month or food intake of 50-75% in the last week before hospital admission] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both .

Exclusion criteria

  • after surgery
  • unable to ingest oral nutrition
  • need for long-term nutrition,
  • terminal condition
  • acute pancreatitis or acute liver failure
  • patients discharged to a nursing home
  • patients unlikely to comply with nutritional support treatment (e.g., dementia)
  • COVID-Hospitalisation requiring intensive care

Treatment and study plan

Nutritional Supplement

Dietary Supplement

daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).

individualized nutritional guidelines

Other

nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.

general nutritional information

Other

general information about health food behavior upon hospital discharge

Primary outcomes

  1. time to death from any cause (i.e., all-cause mortality)

    Time frame: Enrollment to 3 years

    time to death from any cause (i.e., all-cause mortality)

Secondary outcomes

  1. Time to non-elective hospital readmission after discharge from the index hospital stay

    Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]

    Time to non-elective hospital readmission after discharge from the index hospital stay

  2. Time to the first major complication

    Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]

    time to the first major complication including death, bacterial infection with need for antibiotic treatment, major cardiovascular event (i.e., stroke, intracranial bleeding, cardiac arrest, myocardial infarction) or pulmonary embolism, acute renal failure, gastro-intestinal events (including hemorrhage, intestinal perforation, acute pancreatitis)

  3. Changes in functional status measured by the Barthel's index

    Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]

    Changes in functional status measured by the Barthel's index (scores range from 0 to 100, with higher scores indicating better functional status)

  4. Changes in quality of life measured with the European Quality of Life 5 Dimensions index (German Version, EQ-5D index)

    Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]

    Changes in quality of life measured with the European Quality of Life 5 Dimensions index (German Version, EQ-5D index values range from 0 to 1, with higher scores indicating better quality of life)

  5. Changes in quality of life measured with the visual-analogue scale (EQ-5D VAS)

    Time frame: assessed from Day 0 (study enrolment), then every 6 month through phone calls up to end of trial (approx 3 years)]

    Changes in quality of life measured with the visual-analogue scale (EQ-5D VAS) (scores range from 0 to 100, with higher scores indicating better health status).

Other outcomes

  1. Change in body weight

    Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits

    Change in body weight

  2. Change in calf circumference to assess muscle mass

    Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits

    Change in calf circumference to assess muscle mass

  3. Change in bioelectrical impedance analysis (BIA) to assess body composition

    Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits

    Change in bioelectrical impedance analysis (BIA) to assess body composition

  4. Change in hand grip by means of handgrip strength through dynamometry (North Coast Medical Exacta™ Hydraulic Hand Dynamometer) to assess muscle strength

    Time frame: assessed from Day 0 (study enrolment), then at 3, 6 and 12 months by home visits

    Change in hand grip by means of handgrip strength through dynamometry (North Coast Medical Exacta™ Hydraulic Hand Dynamometer) to assess muscle strength

Study contacts

Contact information is provided by the study sponsor or research team.

Philipp Schuetz, Prof. Dr. med.

CONTACT

[email protected]

+41 (0) 62 838 9524

Sponsors and collaborators

Lead sponsor

Philipp Schuetz

Other

Registry information

Official study title

Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery Trial: The EFFORT II Project

Acronym: EFFORT II

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Jun 15, 2021
Registry last updated
Nov 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.